HYPR
Hyperfine IncKey Statistics
About Hyperfine Inc
Hyperfine Inc. is a pioneer in medical technology, focusing on transforming access to MRI with innovative point-of-care imaging solutions. As the developer of the first FDA-cleared portable MRI system, the company significantly enhances patient care by delivering high-quality imaging directly at the bedside, which streamlines clinical decision-making. By emphasizing cost efficiency and patient convenience, Hyperfine is strategically positioned to capitalize on the escalating demand for advanced diagnostic imaging solutions in a rapidly changing healthcare environment. Its groundbreaking technology is poised to make a substantial impact on healthcare delivery across various medical settings, representing a promising opportunity for institutional investors.
Fundamentals
| Revenue (TTM) | $13.56M |
| Gross Profit (TTM) | $6.75M |
| EBITDA | $-35.99M |
| Operating Margin | -144.90% |
| Return on Equity | -79.00% |
| Return on Assets | -40.60% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $0.42 |
| Price-to-Book | 2.70 |
| Price-to-Sales (TTM) | 8.02 |
| EV/Revenue | 5.59 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 128.00% |
| Shares Outstanding | $82.90M |
| Float | $78.40M |
| % Insiders | 6.75% |
| % Institutions | 16.72% |